Work

Long–Term Survival of Allogeneic Transplantation(Allo SCT) In Selected Patients with Multiple Myeloma (MM): Disease Free Survival at Two Years May Indicate Long Term Survival

Year: 2009

Type: article

Abstract: Introduction: Allo SCT offers long term control and in some cases cure in patients with MM. In this study we reviewed our experience at H. Lee Moffitt Cancer Center, of Allo SCT for MM and examined indicators of long term survival.

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2008.12.331

Authors: J. Raychaudhuri, J. Perkins, M. Alsina, J.L. Ochoa-Bayona, H. Fernandez, D. Sullivan, W. Dalton, M. Kharfan-Dabaja, T. Field, E. Ayala, L. Perez, J.C. Harris, W. Janssen, C. Tate, C. Anasetti

Institution: Moffitt Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W2104873490

FWCI:

Cites:

Cited by:

Related to: 10